Zobrazeno 1 - 10 of 596 pro vyhledávání: '"Muri, L."'
1
Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b
Autor: Muri, L., Schubart, A., Thorburn, C., Zamurovic, N., Holbro, T., Kammüller, M., Pluschke, G., Ispasanie, E.
Publikováno v: Frontiers in Immunology. 13
Defense againstHaemophilus influenzaetype b (Hib) is dependent on antibodies and complement, which mediate both serum bactericidal activity (SBA) and opsonophagocytosis. Here we evaluated the influence of capsule-specific antibodies and complement in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88a0322021470bb5a757a1705d7b65c
https://doi.org/10.3389/fimmu.2022.1020580
Zobrazit plný text záznamu
2
Akademický článek
In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway.
Autor: Ispasanie E; Swiss Tropical and Public Health Institute, Molecular Immunology Unit, Basel, Switzerland.; University of Basel, Basel, Switzerland., Muri L; Swiss Tropical and Public Health Institute, Molecular Immunology Unit, Basel, Switzerland.; University of Basel, Basel, Switzerland., Schmid M; Swiss Tropical and Public Health Institute, Molecular Immunology Unit, Basel, Switzerland.; University of Basel, Basel, Switzerland., Schubart A; Novartis Institutes for Biomedical Research, Department Autoimmunity, Transplantation and Inflammation, Basel, Switzerland., Thorburn C; Novartis Pharma AG, London, United Kingdom., Zamurovic N; Novartis Institutes for Biomedical Research, Translational Medicine-Preclinical Safety, Basel, Switzerland., Holbro T; Global Drug Development, Novartis Pharma AG, Basel, Switzerland., Kammüller M; Novartis Institutes for Biomedical Research, Translational Medicine-Preclinical Safety, Basel, Switzerland., Pluschke G; Swiss Tropical and Public Health Institute, Molecular Immunology Unit, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Publikováno v: Frontiers in immunology [Front Immunol] 2023 Jun 29; Vol. 14, pp. 1180833. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023).
Zobrazit plný text záznamu
3
Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems
Autor: Erb, S, Letang, E, Glass, TR, Natamatungiro, A, Mnzava, D, Mapesi, H, Haschke, M, Duthaler, U, Berger, B, Muri, L, Bader, J, Marzolini, C, Elzi, L, Klimkait, T, Langewitz, W, Battegay, M, Asantiel, Aschola, Chale, Adolphina, Faini, Diana, Felger, Ingrid, Francis, Gideon, Furrer, Hansjakob, Gamell, Anna, Glass, Tracy, Hatz, Christoph, Hatz, Speciosa, Kasuga, Bryson, Kalinjuma, Aneth V, Kimera, Namvua, Kisunga, Yassin, Luhombero, Antonia, Luwanda, Lameck B, Mbwile, Leticia, Mkulila, Mengi, Mkumbo, Julius, Mkusa, Margareth, Mossad, Germana, Mpundunga, Dolores, Msami, Daimon, Mtandanguo, Athumani, Mwamelo, Kim D, Myeya, Selerine, Nahota, Sanula, Ndaki, Regina, Ngulukila, Agatha, Ntamatungiro, Alex John, Samson, Leila, Sikalengo, George, Tanner, Marcel, Vanobberghen, Fiona
Publikováno v: Erb, S; Letang, E; Glass, T R; Natamatungiro, A; Mnzava, D; Mapesi, H; Haschke, Manuel Martin; Duthaler, U; Berger, B; Muri, L; Bader, J; Marzolini, C; Elzi, L; Klimkait, T; Langewitz, W; Battegay, M (2017). Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems. HIV medicine, 18(9), pp. 623-634. Blackwell Science 10.1111/hiv.12499
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
HIV Medicine
Objectives: Self-reported adherence assessment in HIV-infected patients on antiretroviral therapy (ART) is challenging and may overestimate adherence. The aim of this study was to improve the ability of health care providers to elicit patients’ rep
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c1ae19b140d45ea42918a96b81fb513
http://hdl.handle.net/2445/109147
Zobrazit plný text záznamu
4
Akademický článek
Alternative Complement Pathway Inhibition Abrogates Pneumococcal Opsonophagocytosis in Vaccine-Naïve, but Not in Vaccinated Individuals.
Autor: Muri L; Molecular Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Ispasanie E; Molecular Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Schubart A; Translational Medicine-Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland., Thorburn C; Novartis Pharma AG, Global Drug Development, London, United Kingdom., Zamurovic N; Translational Medicine-Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland., Holbro T; Novartis Pharma AG, Global Drug Development, Basel, Switzerland., Kammüller M; Translational Medicine-Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland., Pluschke G; Molecular Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Publikováno v: Frontiers in immunology [Front Immunol] 2021 Oct 11; Vol. 12, pp. 732146. Date of Electronic Publication: 2021 Oct 11 (Print Publication: 2021).
Zobrazit plný text záznamu
5
Akademický článek
Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals.
Autor: Ispasanie E; Molecular Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Muri L; Molecular Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Schubart A; Translational Medicine-Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland., Thorburn C; Global Drug Development, Novartis Pharma AG, London, United Kingdom., Zamurovic N; Translational Medicine-Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland., Holbro T; Global Drug Development, Novartis Pharma AG, Basel, Switzerland., Kammüller M; Translational Medicine-Preclinical Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland., Pluschke G; Molecular Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Publikováno v: Frontiers in immunology [Front Immunol] 2021 Oct 08; Vol. 12, pp. 747594. Date of Electronic Publication: 2021 Oct 08 (Print Publication: 2021).
Zobrazit plný text záznamu
6
Akademický článek
Recovery after human bone marrow mesenchymal stem cells (hBM-MSCs)-derived extracellular vesicles (EVs) treatment in post-MCAO rats requires repeated handling.
Autor: Gomez-Galvez, Yolanda1,2,3 (AUTHOR), Gupta, Malvika4 (AUTHOR), Kaur, Mandeep4 (AUTHOR), Fusco, Salvatore5,6 (AUTHOR), Podda, Maria Vittoria5,6 (AUTHOR), Grassi, Claudio5,6 (AUTHOR), Srivastava, Amit K.4 (AUTHOR), Iacovitti, Lorraine1,2,3,7 (AUTHOR) lorraine.iacovitti@jefferson.edu, Blanco-Suarez, Elena1,2,3,7 (AUTHOR) elena.blancosuarez@jefferson.edu
Publikováno v: PLoS ONE. 10/21/2024, Vol. 19 Issue 10, p1-24. 24p.
Zobrazit plný text záznamu
7
Akademický článek
Treatment failure among Sub-Sahara African children living with HIV: a systematic review and meta-analysis.
Autor: Walle, Belete Gelaw1 (AUTHOR) beletegz12@gmail.com, Tiruneh, Chalie Marew2 (AUTHOR), Wubneh, Moges3 (AUTHOR), Chekole, Bogale4 (AUTHOR), Kassaw, Amare2 (AUTHOR), Assefa, Yibeltal5 (AUTHOR), Abebe, Kelemu6 (AUTHOR), Yigzaw, Zeamanuel Anteneh7 (AUTHOR)
Publikováno v: Italian Journal of Pediatrics. 10/1/2024, Vol. 50 Issue 1, p1-10. 10p.
Zobrazit plný text záznamu
9
Akademický článek
Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
Autor: Le ND; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51, 3001, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland., Muri L; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51, 3001, Bern, Switzerland., Grandgirard D; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51, 3001, Bern, Switzerland., Kuhle J; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland., Leppert D; Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland., Leib SL; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51, 3001, Bern, Switzerland. stephen.leib@ifik.unibe.ch.
Publikováno v: Journal of neuroinflammation [J Neuroinflammation] 2020 Oct 07; Vol. 17 (1), pp. 293. Date of Electronic Publication: 2020 Oct 07.
Zobrazit plný text záznamu
10
Akademický článek
Repetitive transcranial magnetic stimulation activates glial cells and inhibits neurogenesis after pneumococcal meningitis.
Autor: Muri L; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland., Oberhänsli S; Interfaculty Bioinformatics Unit and SIB Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland., Buri M; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland., Le ND; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Bern, Switzerland., Grandgirard D; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland., Bruggmann R; Interfaculty Bioinformatics Unit and SIB Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland., Müri RM; Department of Neurology, University of Bern, Bern, Switzerland., Leib SL; Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
Publikováno v: PloS one [PLoS One] 2020 Sep 11; Vol. 15 (9), pp. e0232863. Date of Electronic Publication: 2020 Sep 11 (Print Publication: 2020).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje